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CHAPTER 1
INTRODUCTION
Fibromyalgia (FM) impacts millions of individuals around the world and is
characterized by widespread chronic pain and tenderness as well as nonrestorative
sleep, fatigue, and stiffness (Wolfe et al., 1990; Wolfe et al., 2010).

It is a costly

condition, both in terms of financial burden as well as disability and reduced quality of
life (Berger et al., 2010; Mease, 2005). In addition, more than 90% of individuals with
FM report poor sleep quality, and this is often described as light and unrefreshing sleep
(Moldofsky, 2008). The high prevalence of sleep disturbance in FM suggests that this
may be a contributing factor to the pain experience.
The relationship of sleep and pain is well established in the literature; however,
the direction of this relationship is unclear. Experimental studies have been conducted
with healthy, pain-free people in order to test the directionality of the sleep and pain
relationship. Studies involving sleep restriction and total sleep deprivation have found
increased pain sensitivity the next day compared with no restriction conditions (Haack &
Mullington, 2005; Onen, Alloui, Gross, Eschallier, & Dubray, 2001; Roehrs, Hyde,
Blaisdell, Greenwald, & Roth, 2006). Research has also found that disrupted sleep
continuity, rather than restricted sleep, is a significant predictor of next day’s pain
(Smith, Edwards, McCann, & Haythornthwaite, 2007). These experimental findings on
individuals without chronic pain conditions suggest that disturbed sleep may amplify the
pain found in individuals with chronic pain.
Studies have also been conducted on chronic pain populations including
rheumatoid arthritis and FM, focusing on how poor sleep results in increased pain.
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Ağargün et al. (1999) found that an increase in subjective sleep problems was
associated with increased pain sensitivity. A similar study by Kolar et al. (1989)
assessed problems with sleeping as well as severity of muscle aching, and found that
sleeping difficulties were associated with tenderness and muscular aching that are
characteristic of FM. Longitudinal studies have also found that poor sleep at baseline is
predictive of increased pain after a year (Bigatti, Hernandez, Cronan, & Rand, 2008).
Research has also focused on the impact of pain on subsequent sleep. Nicassio
and Wallston (1992) found that arthritis pain predicted sleep disturbance after 2 years,
but prior sleep disturbance did not predict future pain. Another study by Pilowsky,
Crettenden, and Townley (1985) found that chronic pain patients who slept poorly
reported that they slept fewer hours and also reported significantly higher pain intensity
compared with those who slept normally.
The prevalence of sleep difficulties in individuals with chronic pain, and especially
FM, is very high. The relationship between sleep and pain is evident based on the
literature, although the direction of this relationship remains unclear. Further research is
needed to determine whether there is a stronger relationship between sleep difficulties
and subsequent pain or between pain and subsequent sleep problems, in people with
FM. Research is also needed to explore the factors that predict individual differences in
this sleep and pain relationship.
Goals of this Study
There were two primary goals for this study. The first was to determine the
direction of the sleep and pain relationship in a large sample of individuals diagnosed
with FM. Both objective (actigraphy) and subjective (daily diary) measures of nightly

3
sleep were analyzed to determine the relationship on next day’s pain, as well as
assessing the relationship between one day’s pain on the next night’s objective and
subjective sleep variables. The second goal was to assess factors that may account for
individual differences found in the sleep and pain relationship. Participants completed
self-report measures of depression, negative affect, pain catastrophizing, and age at
baseline, and these were analyzed as potential moderators of the relationship between
sleep and pain.
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CHAPTER 2
LITERATURE REVIEW
Fibromyalgia (FM) is a multifaceted disorder characterized by widespread
chronic pain and tenderness (Wolfe et al., 1990). Since this initial definition of FM was
offered in 1990, the criteria for FM have evolved to include nonrestorative sleep, fatigue,
and stiffness (Wolfe et al., 2010). Fibromyalgia impacts millions of individuals worldwide
and has an estimated prevalence of 2% of adults in the United States (Arnold, 2010),
with an approximately 8:1 female to male ratio (Berger, Dukes, Martin, Edelsberg, &
Oster, 2007; Wolfe, Ross, Anderson, Russell, & Hebert, 1995). The average age of FM
onset is between 30 and 50 years, and the incidence of FM increases with age, rising in
middle age (50-59 years) and dropping in older age groups (80 years and above; Wolfe
et al., 1995).
Fibromyalgia is a costly condition and one of the 100 most common diagnoses
made in family medicine (Arnold, 2010). This debilitating syndrome occurs in 5% to 6%
of adult patients who present at general medical and family practice clinics, and
between 10% and 20% of patients presenting at rheumatology practices (Goldenberg,
Simms, Geiger, & Komaroff, 1990; Wolfe et al., 1995). Two studies of large claims
databases in the United States reported that healthcare costs for people with FM are 2
to 3 times greater than for individuals without FM due to more frequent doctor’s office or
emergency room visits and a greater number of prescription medications (Berger et al.,
2010; White et al., 2008). In addition to the financial burden of FM, many patients also
suffer from disability and reduced quality of life. In a recent review, Mease (2005)
indicated that there is a greater negative impact on quality of life with FM than many
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other diseases, including chronic obstructive pulmonary disease and arthritis. Jones,
Rutledge, Jones, Matallana, and Rooks (2008) conducted a large survey of women with
FM about how this condition has impacted their activities of daily living. They reported
that 25% of the women surveyed had difficulty bathing and taking care of personal
needs, and more than 60% had a difficult time with light housework, lifting or carrying 10
pounds, traveling up or down one flight of stairs, or walking one half mile (Jones et al.,
2008).
In addition to chronic widespread pain and tenderness to touch, individuals with
FM often have a variety of other symptoms and comorbid conditions. Berger and
colleagues (2007) noted in their recent study from a United States health insurance
database that, compared with age and sex-matched patients without FM, those with FM
were more likely to have comorbidities including circulatory disorders, painful
neuropathies, diabetes, gastroesophageal reflux disorder, irritable bowel disorder,
anxiety, depression, and sleep disorders.
Poor sleep quality is reported by more than 90% of individuals with FM, and this
is often characterized as light and unrefreshing sleep (Moldofsky, 2008). In addition to
difficulties falling and staying asleep, a complaint of nonrestorative sleep is common. A
recent review of the literature (Moldofsky, 2009) explored the polysomnographic
(laboratory sleep study) findings of this population and noted the common disturbances
in sleep physiology including delayed sleep onset; reductions in sleep efficiency, slow
wave sleep, and REM sleep; and an increase in motor activity. The high prevalence of
sleep disturbance in FM suggests that this may be a contributing factor to the pain
experience.
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Sleep and Pain
Both pain problems and sleep disorders are considered among the most
common societal complaints, so it is not surprising that these two conditions often cooccur. What is unclear is the direction of the pain and sleep relationship. A literature
review by Moldofsky (2001) indicated that millions of Americans complain that their
experience of nighttime pain interferes with falling asleep, staying asleep, and often
results in early morning awakenings. Contrariwise, disturbances in sleep have also
been found to increase the perception of pain. A micro-longitudinal study by Edwards,
Almeida, Klick, Haythornthwaite, and Smith (2008) found that self-reported sleep one
night was a significant predictor of the next day’s pain, as well as pain frequency
predicting sleep duration the following night. Human studies have also found that
unrefreshing nocturnal sleep in combination with disturbances to sleep physiology result
in increased daytime musculoskeletal pain and fatigue (Moldofsky, 2001). A more
recent literature review by Finan, Goodin, and Smith (2013) suggested that impairments
in sleep may be a more reliable and stronger predictor of pain than pain is of sleep
impairments. I now review this literature on the relation of sleep disturbances and pain.
Experimental Sleep Manipulation and Pain
To test the directionality of the sleep and pain relationship, experimental studies
have been conducted with healthy, pain-free people. A study by Onen et al. (2001)
sought to determine what effect total sleep deprivation, interruptions in slow wave sleep
and rapid eye movement (REM) sleep, and recovery sleep would have on pain
threshold as assessed with a pressure dolorimeter. They found that total sleep
deprivation reduced pain threshold 8% (i.e., increased pain sensitivity) the following
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day. Although neither slow wave sleep nor REM sleep interruptions resulted in a
significantly decreased pain threshold, recovery sleep following the slow wave sleep
interruption led to a 15% increase in pain thresholds. Haack and Mullington (2005)
discovered that two nights of partial sleep restriction (4 hours) resulted in reports of
spontaneous bodily pain, and that pain was amplified with subsequent nights of partial
sleep restriction. Another study by Roehrs et al. (2006) found that both total sleep
deprivation and sleep restriction significantly reduced pain threshold compared with a
no sleep reduction condition. These findings provide support for the strong impact that
sleep restriction has on the next day’s pain.
Research has also examined the role of disrupted sleep continuity and
subsequent pain. Taylor and colleagues (2007) examined the comorbidity of medical
problems and insomnia and discovered that the most common sleep complaint of
individuals with chronic pain is multiple awakenings throughout the night as a result of
pain-related arousals. Smith et al. (2007) developed a sleep disruption paradigm that
awakens participants pseudorandomly each hour during an 8-hour sleep period in order
to mimic the continuity disturbance reported by individuals with chronic pain. They
discovered that healthy female participants who had disrupted sleep continuity reported
spontaneous pain the following day compared with participants who had an equivalent
amount of restricted sleep and healthy controls who had uninterrupted sleep for 8 hours.
These findings suggest that the disruption of continuous sleep may be an even stronger
predictor of subsequent pain than restriction of sleep.
Other research has examined pain sensitivity of sleepy but healthy individuals.
One study by Chhangani and colleagues (2009) compared the pain sensitivity of sleepy
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versus alert healthy individuals. The sleepy participants had a reduced pain threshold
compared with the alert participants. Another study by Roehrs, Harris, Randall, and
Roth (2012) increased the amount of sleep allowed over 4 nights in sleepy but pain-free
individuals. This increased time in bed resulted in decreased pain sensitivity compared
with controls who maintained their regular sleep schedule. These studies provide
support for the pathway that alterations in sleep influence pain perception.
Even participants without chronic pain conditions experience a significant
decrease in pain threshold when sleep is reduced, disrupted, or eliminated. Therefore,
these experimental findings on people without chronic pain conditions suggest that
disturbed sleep quality and duration in individuals with chronic pain, such as rheumatoid
arthritis (RA) and FM, may contribute to their increased pain.
Sleep and Pain in Chronic Pain Conditions
Studies have examined how poor sleep predicts increased pain among people
with RA. A recent study by Irwin and colleagues (2012) restricted the sleep (4 hours) of
both healthy participants and individuals with RA. They found that one night of partial
sleep deprivation resulted in increased self-reported fatigue, anxiety, depression, and
pain for the participants with RA, but not for the healthy controls. Moldofsky, Lue, and
Smythe (1983) studied the impact that disturbed sleep has on the morning symptoms
experienced by people with RA. The patients were found to have an alpha
electroencephalographic (EEG) sleep anomaly and subsequent arousal state during
sleep as well as an increase in peripheral joint tenderness the following morning. A
similar study compared two groups of patients with RA: those who complained of
morning symptoms and those who were free of such symptoms (Moldofsky, Lue, &

9
Saskin, 1987). Those patients with morning symptoms had fragmented sleep
characterized by periodic leg movements and repetitive electroencephalographic (EEG)
arousals compared with those patients without morning symptoms. These studies
suggest that a nonrestorative sleep disorder may lead to bodily symptoms upon
awakening.
Several studies have also been conducted with FM, focusing on how poor sleep
results in increased pain. Ağargün et al. (1999) examined the association between pain
threshold, measured with a manual algometer, and subjective sleep quality. They found
that an increase in sleep problems was associated with a decreased pain threshold,
suggesting that greater sleep disturbance is associated with increased pain sensitivity in
FM.
Theadom, Cropley, and Humphrey (2007) explored the effect of sleep and coping
on pain in FM. Participants were asked to complete self-report measures on sleep
quality, forms of coping, and pain. They found that 99% of participants reported poor
sleep quality and that this was significantly related to pain, whereas coping strategies
were not related to pain.
Bigatti et al. (2008) conducted a longitudinal study that assessed whether
baseline sleep predicted subsequent pain in participants with FM. They had participants
complete self-report questionnaires on sleep quality and pain at both baseline and at a
1-year follow-up assessment. The results suggest that poor sleep is predictive of
subsequent pain in the FM population, even after a year.
Another study that looked at the sleep and pain relationship had participants with
chronic, widespread, unexplained muscular aching—which is characteristic of FM—
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assess the severity of their muscle aching as well as any problems with sleeping
including falling asleep, frequent nocturnal awakenings, or waking too early (Kolar et al.,
1989). The results of this study indicate that sleeping difficulties are associated with the
tender points and muscular aching that are characteristic of FM. Similarly, Davies et al.
(2008) followed individuals with chronic widespread pain over a period of 15 months
and found that those participants who reported good quality sleep at the end of the
study had a resolution of their pain symptoms. These results suggest that restorative
sleep may improve the long-term prognosis of individuals with chronic pain.
Finally, Tang, Goodchild, Sanborn, Howard, and Salkovskis (2012) examined the
temporal link between sleep and pain in individuals with various chronic pain conditions
and concomitant insomnia. Participants wore an Actiwatch, a small, watch-like device
that measures movement and activity level with an embedded accelerometer, and
completed electronic daily diaries with questions about sleep, pain, mood, and arousal,
for 7 days. They found that sleep quality was a predictor of pain the next morning, but
that the effect of high quality sleep did not extend into the following afternoon. Results
also indicate that pre-sleep pain was not a reliable predictor of the subsequent night’s
sleep. Rather, sleep was significantly predicted by pre-sleep cognitive arousal.
These studies of the effects of experimentally manipulated sleep on pain as well
as the studies conducted with chronic pain populations support the hypothesis that poor
sleep increases pain. Yet there are another set of studies that have examined the
impact of pain on subsequent sleep.
To examine whether the presence of pain predicts subsequent poor sleep,
Pilowsky et al. (1985) compared the amount of pain experienced between chronic pain
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patients who slept poorly with those who slept comparatively well. The poor sleepers
indicated that they slept fewer hours and reported significantly higher pain intensity
compared with those patients who stated that they slept normally. Another study looked
at how pain predicts poor sleep in a RA sample. Nicassio and Wallston (1992) collected
self-report data on sleep disturbance and pain at two different time points within a 2year period. Longitudinal regression analyses indicated that arthritis pain predicted
sleep disturbance after 2 years, but prior sleep disturbance was not found to have an
impact on subsequent pain. These studies provide support for the impact of pain on
subsequent sleep. A final category of studies, which I will now review, have found a
bidirectional relationship between pain and sleep.
Bidirectional Relationship between Pain and Sleep
The first study examining the bidirectional relationship between pain and sleep
was conducted by Affleck, Urrows, Tennen, Higgins, and Abeles (1996) who were
interested in determining the effect of attention to pain on nightly sleep. Women with a
diagnosis of FM used palm-top computers to answer daily self-report questions about
sleep, pain, and attention to pain. They discovered that reports of greater pain during
the day predicted a worse night’s sleep, and that increased attention to pain also
predicted poorer sleep. In addition, those individuals who reported sleeping poorly also
reported more pain and more attention to pain the following day. This study suggests
that the direction of the sleep-pain relationship may not be conclusive and suggests that
more research is needed, particularly within FM.
Another study, which has many design features that parallel the current study,
evaluated the influence of depression on the bidirectional relationship between sleep
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and pain in chronic pain patients (O’Brien et al., 2011). Twenty-two women with various
forms of chronic pain including facial pain, back pain, and fibromyalgia, completed selfreport measures of sleep and pain at baseline as well as daily assessments of sleep
and pain. Participants wore an Actiwatch for 2 weeks and also completed 2 weeks’
worth of sleep diaries and pain ratings. Hierarchical linear modeling analyses indicated
that there was a bidirectional relationship between subjectively-reported sleep and pain,
in that a day of increased pain was followed by a night of disrupted sleep, and a night of
disrupted sleep was followed by increased pain the next day. Analyses on objective
measures of sleep collected with actigraphy found no significant relationships among
the sleep and pain variables. O’Brien and colleagues (2011) suggested that the
subjective experience of sleep has a stronger relationship with reports of pain compared
with more objective sleep measures.
There is a high prevalence of sleep difficulties in people with chronic pain, and
especially FM. Although these studies differ on the directionality of the sleep and pain
relationship, it is evident that there is a relationship between these two factors. Further
research is needed to determine whether there is a stronger relationship between pain
and subsequent sleep difficulties, or between sleep problems and subsequent pain, in
people with FM. In addition, research is needed to explore the factors that predict
individual differences in this sleep and pain relationship.
Moderators of the Sleep and Pain Relationship in Fibromyalgia
There are several factors that may aid in predicting the direction and the strength
of the relationship between sleep and pain in FM. Unfortunately, there is almost no
literature to guide the study of predictors, but I proposed to examine age, depression,
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and pain catastrophizing. Theory and an occasional study suggest that these factors
may predict the direction and strength of the sleep-pain relationship in FM.
A recent longitudinal study by Mork and Nilsen (2012) evaluated the relationship
between self-reported sleep difficulties and risk of developing FM. Adult women who did
not have a diagnosis of FM or any other chronic pain condition were included in the
study and asked to indicate frequency of sleep problems. These same women were
assessed approximately 10 years later for the presence of FM. The results indicate that
the women who developed FM during the follow-up period reported a greater incidence
of sleep difficulty at baseline compared with those who did not develop FM. When the
women were stratified into older (≥45 years) and younger (20-44 years) age groups, the
relative risk of FM development was greater for those women in the older group who
reported sleep problems, compared with the women in the younger group (Mork &
Nilsen, 2012). This study speaks to both direction and strength of the sleep-pain
relationship. It suggests that sleep disturbance may result in FM-related pain, and older
individuals with sleep difficulties may be at greater risk of developing FM than younger
individuals. Additional studies provide evidence for significant sleep disruptions in older
individuals with chronic pain (Lunde, Pallesen, Krangnes, & Nordhus, 2010) as well as
associations of daily sleep and pain in older individuals with insomnia (Dzierzewski et
al., 2010). These findings suggest that age is an important potential moderator in the
sleep-pain relationship.
One of the prevalent comorbidities found with FM is depression, which may
impact sleep fragmentation and sleep loss (Berger et al., 2007; Roehrs & Roth, 2005). A
recent study by Miró, Martínez, Sánchez, Prados, and Medina (2011) evaluated the role
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of sleep problems as a mediator of pain intensity on depression. Women with a FM
diagnosis completed several self-report measures including pain, sleep, and
depression. Compared with control participants, those with FM had significantly poorer
sleep and greater levels of depression. Poor sleep quality was significantly correlated
with greater pain intensity and depression, and pain intensity was also significantly
correlated with depression levels (Miró et al., 2011). The study described earlier by
O’Brien and colleagues (2011) evaluated the influence of depression on the relationship
between sleep and pain in patients with chronic pain. In addition to finding a
bidirectional relationship between sleep and pain, depressive symptoms also moderated
this relationship, with participants who reported higher baseline depression levels
having a stronger sleep-pain relationship than those with lower baseline levels of
depression. Both of these studies speak to the strength of the sleep and pain
relationship, suggesting that individuals with higher levels of self-reported depression
symptoms have a stronger relationship between sleep and pain than individuals with
lower levels of depression.
Pain catastrophizing impacts how individuals experience pain. Campbell,
Edwards, and Quartana (2009) define pain catastrophizing “as a set of exaggerated and
negative cognitive and emotional schema brought to bear during actual or anticipated
painful stimulation.” People who catastrophize tend to do three things: they ruminate
about their pain, they magnify the severity of their pain, and they feel helpless to
manage their pain (Sullivan, Bishop, & Pivik, 1995). As a result, individuals who
catastrophize often attempt to avoid or escape painful experiences (Gatchel, Peng,
Peters, Fuchs, & Turk, 2007). Pain catastrophizing has been associated with pain
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sensitivity in experimental pain testing both with healthy individuals and those with
chronic pain conditions (Edwards, Bingham, Bathon, & Haythornthwaite, 2006; Sullivan
et al., 2001). A study by Severeijns, Vlaeyen, van den Hout, and Weber (2001)
examined the relationship between pain catastrophizing and pain intensity and
psychological distress in individuals with chronic pain. This study did not examine the
sleep and pain relationship; instead, this study assessed chronic pain patients, who are
known to have disturbed sleep, and discovered that those individuals who
catastrophized experienced greater pain intensity and more psychological distress
including depression. This suggests that individuals with chronic pain, who most likely
have disturbed sleep as well, will experience greater pain intensity with catastrophizing
compared with those who do not catastrophize about their pain.
Aims of this Study
The review of the literature provides evidence that sleep and pain are related.
Experimental sleep manipulation studies resulted in alterations of pain perception, and
chronic pain populations indicated that poor sleep often resulted in increased pain as
well as the presence of pain resulting in disrupted sleep. The purpose of this study was
to determine the direction of the sleep-pain relationship in a FM population as well as to
uncover any potential factors that might predict individual differences in the sleep-pain
relationship.
The prior literature with chronic pain populations relied almost exclusively on selfreports of sleep to evaluate the relationship between sleep and pain. Very few studies
have evaluated daily sleep with an objective measure of actigraphy (O’Brien et al.,
2011; Tang et al., 2012), and these have included only heterogeneous pain populations.
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The goal of this study was to evaluate the relationship between sleep and pain using a
large sample of individuals with FM. Sleep was objectively measured with 2 weeks of
actigraphy along with subjective daily sleep diaries and pain ratings. Baseline self-report
measures of depression, pain catastrophizing, negative affect and age were also
evaluated to determine if any of these factors might explain individual differences in the
sleep / pain relationship.
Aim 1. To determine the direction of the sleep-pain relationship for a sample of
patients with FM. The current literature is unclear regarding direction of the relationship
between sleep and pain. This study utilized both objective (actigraphy) and subjective
(daily diary) measures to analyze this relationship. Separate analyses evaluated how
one night’s subjective and objective sleep variables influenced the next day’s selfreported pain, as well as how one day’s reported pain influenced the following night’s
subjective and objective sleep variables. Baseline predictor variables (depression,
negative affect, pain, sleep quality, pain catastrophizing, and age) were also analyzed to
determine their effect on the objective and subjective sleep variables as well as selfreported daily pain.
Aim 2. To determine what factors predict individual differences in the relationship
between sleep and pain. Age, depression, negative affect, and pain catastrophizing
were each evaluated as potential moderators of this relationship. Based upon the
literature review, it was predicted that older individuals, as well as those who endorse
more depression, negative affect, and pain catastrophizing would have a stronger
relationship between sleep and pain.
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CHAPTER 3
METHOD
Participants
Participants were 90 adults, aged 21 to 74, who were diagnosed with
fibromyalgia (FM) and recruited as part of a National Institute of Health randomized
clinical trial for FM interventions. Although this was a multi-center trial, including Wayne
State University and the University of Michigan, the current data were taken solely from
the Wayne State University site. There were 85 women (94.4%) and 5 men (5.6%), and
they identified themselves as Caucasian (67.8%), African American (25.5%), or other
(6.7%). Participants met the 1990 ACR criteria and/or the modified 2010 ACR FM
criteria to be included in the study. Potential participants were excluded from the study if
they had co-morbid autoimmune disorders (e.g., rheumatoid arthritis, systemic lupus
erythematosus) or any other serious medical condition that could have impaired health
status independently of FM including cardiopulmonary disorders (e.g. COPD, CHF),
uncontrolled endocrine or allergic disorders, or malignancy within the previous 2 years.
Other exclusion criteria included current psychotic disorder, dissociative identity
disorder, alcohol or drug dependence in the past 2 years, or active suicide risk.
Individuals with cognitive impairment or dementia, who were unable to fluently read or
converse in English, or who had pending (or recently received) FM-related litigation,
disability, or workman’s compensation were also excluded.
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Procedure
Screening
Participants recruited for the clinical trial were screened by telephone for FM
symptoms, litigation/disability status, and co-morbid autoimmune disorders. Individuals
who passed the telephone screening criteria and remained interested in participating
were screened in person by the study coordinator.
An in-person screening was conducted with each participant at a convenient
location (i.e., Detroit, Farmington Hills, or Macomb). Participants completed the written
informed consent document, approved by the Human Investigation Committee of
Wayne State University. The study coordinator obtained demographic and medical
history information and ensured that the participants met the diagnostic criteria for FM
(Wolfe et al., 1990; Wolfe et al., 2010). Tender point counts were assessed with the
standard procedure for applying pressure in the Manual Tender Point Survey (MTPS)
using the thumb pad of the examiner’s dominant hand (Okifuji, Turk, Sinclair, Starz, &
Marcus, 1997). The FM Symptom scale (FS) was also assessed by combining the
Widespread Pain Index (WPI) and modified Symptom Severity scale (SS) as described
in the modified ACR 2010 FM criteria (Wolfe et al., 2011). The participants completed a
number of self-report measures not used in this dissertation and received $50 for the
screening visit.
Baseline evaluation
Participants were asked to return for an in-person evaluation session conducted
by a research assistant. Each participant was assessed for changes in health,
medications, disability claims, and recent stressors since the screening visit. Those
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participants who still met study inclusion criteria completed a battery of self-report
measures, including the Center for Epidemiological Studies Depression Scale (CES-D;
Radloff, 1977), Pain Catastrophizing Scale (PCS; Sullivan et al., 1995), Brief Pain
Inventory (BPI; Cleeland & Ryan, 1994), Pittsburgh Sleep Quality Index (PSQI; Buysse,
Reynolds, Monk, Berman, & Kupfer, 1989), Positive and Negative Affect Schedule
(PANAS; Watson, Clark, & Tellegen, 1988) and others that were not used in this
dissertation. The baseline evaluation also included experimental pain testing and heart
rate variability (HRV) recording, neither of which was included in this dissertation. At the
conclusion of the evaluation session, each participant was taught how to use an
Actiwatch (Mini-Mitter, Respironics, Inc.) and was given one of these devices to wear for
the following 2 weeks. In addition to wearing the Actiwatch, participants completed an
activity log each day for the 2-week period (Appendix A). The activity log provided
context for the movement data that was recorded with actigraphy. Participants were
asked to record their average pain level for the entire day prior to bed each night. They
also completed a set of morning questions upon awakening that pertained to the
previous night’s sleep. These questions included what time the participants attempted to
fall asleep, how long they took to fall asleep, what time they woke to begin their day,
and how refreshed they felt after their previous night’s sleep. In addition, participants
were requested to write down each time the Actiwatch was removed and for how long
the device was off the wrist. The participants received $100 for the evaluation visit and
$50 for returning the Actiwatch after 2 weeks.
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Measures
Prospective Daily Measures
This dissertation assessed daily sleep and pain ratings recorded with the
Actiwatch (Mini-Mitter, Respironics, Inc.) and activity log.
Actiwatch. The Actiwatch (Mini-Mitter, Respironics, Inc.) is a lightweight activity
and movement monitor that is worn on the non-dominant wrist. It provides an objective
behavioral measurement of sleep by recording activity throughout the day and night with
an accelerometer. Participants wore this device for a 2-week period, and their activity
data was translated into either “wake” or “sleep” based on a standard, validated
algorithm that applies correction factors derived from polysomnography (Philips
Respironics, 2009). The Actiware scoring software is both reliable and valid for
estimating sleep statistics when compared with traditional laboratory methods of sleep
measurement (Cellini, Buman, McDevitt, Ricker, & Mednick, 2013). Data was recorded
in 1-minute epochs throughout the study period, and actigraphy data was cleaned and
scored with reference to diary data obtained from the activity log. For example, the
information written in the activity log regarding what time the participants attempted to
fall asleep and what time the participants woke to start their day aided in creating
accurate rest and active intervals. The time and duration that the participants wrote
down for when the watch was removed also aided in creating accurate exclusion
intervals. The cleaned and scored actigraphy data produced several sleep and wake
statistics. The variables of interest for this study were time in bed (TIB; the number of
minutes in the nighttime rest interval), sleep onset latency (SOL; the number of minutes
scored as wake from the beginning of the nighttime rest interval until the initiation of
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sleep), total sleep time (TST; the number of minutes during the nighttime rest interval
scored as sleep), wake after sleep onset (WASO; the number of minutes within the TST
interval scored as wake), and sleep efficiency (SE; the percentage of scored total sleep
time to the time in bed interval).
Daily activity log. In addition to wearing the Actiwatch, participants were asked to
complete a daily activity log with subjective sleep information and to rate their average
daily pain severity. The activity log produced several self-reported sleep and wake
statistics including time in bed (SRTIB), sleep onset latency (SRSOL), total sleep time
(SRTST), wake after sleep onset (SRWASO), sleep efficiency (SRSE), and refresh
score (RS; an indication of how refreshed the participant felt after the previous night’s
sleep). Refresh score was measured on a scale from 0 to 10 where 0 represents “not at
all refreshed” and 10 indicates “completely refreshed.” All of the self-reported sleep
variables were recorded in the morning upon awakening. Average pain was measured
on a scale from 0 to 10 where 0 represents “no pain” and 10 indicates “pain as bad as
you can imagine.” This daily value was recorded in the activity log as well as in the
Actiwatch prior to bed each night.
Baseline Measures
Depression. The Center for Epidemiological Studies Depression Scale (CES-D;
Radloff, 1977) contains 20 items that measure depressive symptomatology. Participants
were instructed to focus on their depressed mood during the past week when
completing the items. Each item was scored from 0 to 3 where 0 indicates “rarely or
none of the time” and 3 represents “most or almost all the time.” The scale can be
analyzed either as a continuous measure of depressive symptoms or as a dichotomous
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measure, with scores of 16 or greater indicating symptom levels suggestive of
depression. Normative studies of women scoring 16 or above on the CES-D have found
rates between 8.7% and 17.4% (Knight, Williams, Mcgee & Olaman, 1997; Myers &
Weissman, 1980; Roberts & Vernon, 1983). Several studies have found that the
established cutoff of 16 for the CES-D overestimates the prevalence of depression in
non-clinical samples (Beekman et al., 1997; Santor, Zuroff, Ramsay, Cervantes, &
Palacios, 1995; Roberts, Lewinsohn, & Seeley, 1991). Therefore, a cutoff of 20 was
used in this dissertation as an estimate of probable depression. The CES-D has also
successfully been used to assess depression symptoms across wide age ranges
(Lewinsohn, Seeley, Roberts, & Allen, 1997), an important consideration for the present
dissertation. In this study, the CES-D demonstrated good reliability at baseline
(Cronbach’s alpha = 0.70).
Pain Catastrophizing. The Pain Catastrophizing Scale (PCS; Sullivan et al.,
1995) contains 13 statements about pain. Participants were instructed to indicate the
degree to which they have the thoughts and feelings listed when they experience pain,
from 0 meaning “not at all” to 4 meaning “all the time.” The total scale is dichotomous
with scores of 30 or greater indicating a clinically relevant level of catastrophizing. For
this dissertation, a mean score of the 13 items was used to assess overall pain
catastrophizing, and this scale demonstrated excellent reliability at baseline (Cronbach’s
alpha = 0.93).
Brief Pain Inventory. A modified version of the Brief Pain Inventory (BPI;
Cleeland & Ryan, 1994) was used in this dissertation. Participants were asked to
answer four questions about their worst, least, and average pain over the past week, as
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well as their current level of pain at the time of assessment. Each of these questions
was scored on a 0 to 10 scale where 0 represents “no pain” and 10 indicates “pain as
bad as you can imagine.” A mean score for all four pain severity items was calculated
and utilized in analyses as an index of baseline pain, and this measure demonstrated
good internal consistency (Cronbach’s alpha = 0.85).
Pittsburgh Sleep Quality Index. The Pittsburgh Sleep Quality Index (PSQI;
Buysse et al., 1989) contains 19 self-rated questions related to usual sleep habits
during the past month. These items were combined to form seven “component” scores
(i.e., subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency,
sleep disturbances, use of sleeping medication, and daytime dysfunction), all of which
were scored on a 0 to 3 scale where 0 indicates “no difficulty” and 3 represents “severe
difficulty.” The seven component scores were added to yield a global PSQI score with a
range of 0 to 21 points that was utilized in analyses as an index of baseline sleep
quality. In this study, global PSQI demonstrated an acceptable level of reliability at
baseline (Cronbach’s alpha = 0.64).
Positive and Negative Affect Schedule. The Positive and Negative Affect
Schedule (PANAS; Watson et al., 1988) contains 20 words and phrases that describe
different feelings and emotions. Participants were instructed to indicate to what extent
they felt each descriptor over the past few weeks on a scale from 1 to 5 where 1
represents “very slightly or not at all” and 5 indicates “extremely.” Mean positive affect
and negative affect scores were calculated from the 10 words and phrases that loaded
onto each construct. In this study, internal consistency was excellent for both positive
affect (Cronbach’s alpha = 0.91) and negative affect (Cronbach’s alpha = 0.90). These
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variables were utilized in analyses to determine if the depression variable (CES-D)
assessed unique variance in addition to negative affect.
Data Analysis
The actigraphy data was cleaned and scored with reference to the daily activity
log with subjective sleep information as noted previously. The resultant objective
variables of time in bed (TIB), sleep onset latency (SOL), total sleep time (TST), wake
after sleep onset (WASO), and sleep efficiency (SE) were used in the analyses. The
subjective variables of time in bed (SRTIB), sleep onset latency (SRSOL), total sleep
time (SRTST), wake after sleep onset (SRWASO), sleep efficiency (SRSE), and refresh
score (RS) were also used in the analyses.
Multilevel modeling was utilized for this dissertation due to the hierarchical
structure of the data (14 daily observations nested within persons). This methodology
was able to account for within-person variation (a participant’s daily deviation from their
own 14-day mean) and between-person variation (each participant’s deviation from the
grand mean). In order to model both within- and between-person variation, each daily
predictor variable was represented by two different variables (Hoffman & Stawski,
2009). For each predictor, a within-person variable (Level 1) represented the deviation
from that individual’s mean on a particular day. For each participant and predictor, a
second between-person variable (Level 2) represented that individual’s average for the
predictor across all days (person mean), and the variable was centered so that 0 was
the grand mean.
The data was checked for accuracy and frequency distributions. Several of the
between-person predictor variables were skewed (average sleep onset latency, average
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sleep efficiency, average self-report sleep onset latency, and average self-report wake
after sleep onset). These variables were winsorized and average sleep onset latency
and average self-report wake after sleep onset were log10(x+1) transformed. Results of
correlational analyses did not differ between the original and the winsorized and
transformed variables. Therefore, only original variables were used in subsequent
analyses.
Preliminary analyses assessed the relationships among the baseline predictor
variables of depression, negative affect, pain catastrophizing, sleep quality, pain, and
age. Analyses were also conducted to determine the relationships among the average
objective and subjective sleep predictor variables.
Sleep/Pain Relationship
Two sets of analyses were conducted with multilevel modeling in order to
determine the relationship between daily sleep and pain, each looking at the entire
sample of participants. The first set of analyses described the relationship between the
objective (actigraphy) and subjective (activity log) nightly sleep variables and the next
day’s average pain. The second set of analyses described the relationship between
average daily pain and the subsequent night’s objective and subjective sleep variables.
These analyses addressed the hypothesis about the direction of the sleep / pain
relationship. Analyses were also conducted with multilevel modeling in order to
determine the relationship between the baseline predictor variables and sleep and pain
outcomes.
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Potential Moderator Analysis
To determine what factors may be driving the sleep and pain correlation across
individuals, the potential moderator variables of age, depression, negative affect, and
pain catastrophizing were built into the multilevel model to determine if they were
significant predictors of the relationship between sleep and pain and between pain and
sleep. Each potential moderator was added as a continuous variable and was further
described as a dichotomous variable when a significant interaction term resulted (e.g.,
older vs. younger, high vs. low depression, high vs. low negative affect, and high vs. low
pain catastrophizing).
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CHAPTER 4
RESULTS
Preliminary Analyses
Individuals were included in the analyses if they completed at least 7 days of
actigraphy and daily sleep and pain diaries. Adherence for actigraphy was very high,
with 83 individuals completing at least 12 of the 14 days (M = 13.24 days, SD = 1.34).
Daily sleep and pain diary adherence was also very high, with 86 individuals completing
at least 12 of the 14 days (M = 13.28 days, SD = 1.07).
Analyses were conducted to determine the relationships among the six baseline
predictors: depression (CES-D; M = 20.20, SD = 10.97), negative affect (PANAS; M =
2.01, SD = 0.74), pain catastrophizing (PCS; M = 1.39, SD = 0.84), sleep quality (PSQI;
M = 12.32, SD = 3.99), pain (BPI; M = 5.63, SD = 1.82), and age (M = 50.24, SD =
12.77). Table 1 presents the correlations among the baseline predictors. As shown in
this table, depression and negative affect were highly correlated, as expected (p < .01).
The remainder of the self-reported variables (depression, negative affect, pain
catastrophizing, sleep quality, and pain) were all positively correlated, with most
correlations ranging from r = .26 to r = .49. Interestingly, baseline pain was not
significantly related to baseline depression or negative affect.

Age was inversely

correlated with the other five predictors, with correlations ranging from r = -.16 to r =
-.30.
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Table 1
Correlations among the Baseline Predictor Variables

1. Depression (CESD)
2. Negative Affect (PANAS)

2

3

.79**
---

3. Pain Catastrophizing (PCS)
4. Sleep Quality (PSQI)
5. Pain (BPI)
6. Age

4

5

6

.49**

.42**

.14

-.16

.33**

.26*

.06

-.21

---

.26*

.35**

-.30**

.35**

-.16

---

-.19

---

---

Note. All correlations were 2-tailed.
*p < .05. **p < .01.

Analyses were also conducted to determine the relationships among the daily
objective and subjective sleep outcome variables: time in bed (TIB; M = 495.71 min, SD
= 64.10), sleep onset latency (SOL; M = 16.81 min, SD = 15.80), wake after sleep onset
(WASO; M = 65.92 min, SD = 24.47), total sleep time (TST; M = 401.16 min, SD =
57.52), sleep efficiency (SE; M = 80.47%, SD = 8.85), refresh score (RS; M = 4.0, SD =
1.78), self-report time in bed (SRTIB; M = 500.73 min, SD = 65.42), self-report sleep
onset latency (SRSOL; M = 27.37 min, SD = 20.31), self-report wake after sleep onset
(SRWASO; M = 36.74 min, SD = 34.32), self-report total sleep time (SRTST; M =
440.05 min, SD = 53.85), and self-report sleep efficiency (SRSE; M = 88.09%, SD =
7.39). These descriptive analyses represent the average of each of these daily variables
across the 14 days of data collection.
Table 2 presents the correlations among the average daily sleep variables. As
shown in this table, the subjective measures were more highly correlated with one
another than the objective measures. Importantly, the sleep variables were related to
one another in similar patterns (e.g., as time in bed (TIB) increased, total sleep time
(TST) also increased). Although not significant for either subjective or objective sleep,
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the one exception to the predictable pattern of correlations was found between sleep
onset latency (SOL) and TST; a negative relationship for objective sleep, and a positive
relationship for subjective sleep.
The objective outcome variables of time in bed (TIB), wake after sleep onset
(WASO), and total sleep time (TST), were significantly correlated with their subjective,
self-reported counterparts (p < .01). In contrast, the objective outcome variables of
sleep onset latency (SOL) and sleep efficiency (SE) were not significantly related to
their subjective counterparts. Although self-reported refresh score was significantly
related to other self-reported sleep variables, how refreshed one feels upon awakening
was not significantly correlated with any objective sleep variables.
Table 2
Correlations among the Average Daily Sleep Variables
2

3

1. Time in Bed

.17

.45

†

.80

2. Sleep Onset Latency

---

.19

-.11

---

3. Wake After Sleep Onset
4. Total Sleep Time
5. Sleep Efficiency
6. Refresh Score
7. Self-report Time in Bed
8. Self-report Sleep Onset
Latency
9. Self-report Wake After
Sleep Onset
10. Self-report Total Sleep
Time
11. Self-report Sleep
Efficiency

Note. All correlations were 2-tailed.
†
*p < .05. p < .01.

4

5

6

7

-.03

-.20

.95

†

.54

†

.43

-.70

†

-.03

.23*

.17

-.10

-.54

†

-.12

.50

†

.29

†

.46

---

.39

†

-.11

.72

†

.41

†

.21*

.57

.04

-.11

-.01

-.19

-.03

.14

---

-.24*

-.28

†

-.25*

-.04

.32

---

.55

†

.43

†

.74

†

-.41

†

.37

†

.07

-.65

†

-.18

-.87

†

---

.29

†

---

8

---

9

10
†

-.42

.01

.22*

-.05

†

.25*

-.41

---

†

11

.68

†

†

†

-.23*

---

†
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Each of the Level 1 (within-person) outcome variables of sleep and pain was
then tested to determine if they differed significantly across individuals, that is, whether
participants differed from one another on the daily sleep and pain variables, which is a
prerequisite for further HLM analyses. These were conducted with the intercept-only
model in HLM, which is the equivalent to a one-way, random-effects ANOVA model
(Table 3).
Table 3
HLM One-Way Random Effects ANOVA Model
Equations

Example

Level 1 Model

Level 1 Model

Yij = β0j + rij
Level 2 Model
β0j = γ00 + u0j
Mixed Model
Yij = γ00 + u0j + rij

PS = β0j + rij
Level 2 Model
β0j = γ00 + u0j
Mixed Model
PS = γ00 + u0j + rij

Note. Equations are from Raudenbush and Bryk (2002); PS = Daily pain score

All of the objective and subjective sleep variables as well as daily pain were
significantly different across individuals (p<.001). This signaled that further HLM
analyses were indicated because there was sufficient variation among participants to
warrant an analytic method that would assess daily variation within- and betweenindividuals. Intraclass correlation coefficients (ρ = τ00 / (τ00 + σ2) were also calculated to
determine the percentage of the variance in each outcome variable that was between
individuals (Table 4). The variation between individuals for the objective and subjective
sleep variables of time in bed, sleep onset latency, wake after sleep onset, total sleep
time, and sleep efficiency ranged from 15.3 to 45.1%, indicating that over half of the
variance was found within individuals. In contrast, refresh score and daily pain score
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had intraclass correlation coefficients that were 58.3 and 64.4% respectively, indicating
that there was more variance between- than within-individuals for these variables.
Table 4
Intraclass Correlation Coefficients (ICC) for Each Outcome Variable
Intraclass Correlation Coefficient
(ICC) / % of variance
Objective Variables
Time in Bed (TIB)

ρ = 0.306 / 30.6% *

Sleep Onset Latency (SOL)

ρ = 0.153 / 15.3% *

Wake After Sleep Onset (WASO)

ρ = 0.357 / 35.7% *

Total Sleep Time (TST)

ρ = 0.318 / 31.8% *

Sleep Efficiency (SE)

ρ = 0.451 / 45.1% *

Subjective Variables
Self-report Time in Bed (SRTIB)

ρ = 0.321 / 32.1% *

Self-report Sleep Onset Latency (SRSOL)

ρ = 0.272 / 27.2% *

Self-report Wake After Sleep Onset (SRWASO)

ρ = 0.334 / 33.4% *

Self-report Total Sleep Time (SRTST)

ρ = 0.184 / 18.4% *

Self-report Sleep Efficiency (SRSE)

ρ = 0.267 / 26.7% *

Refresh Score (RS)

ρ = 0.583 / 58.3% *

Daily Pain Score (PS)
*p < .001.

ρ = 0.644 / 64.4% *

Primary Analyses
The intercept-only models indicated the appropriateness of further HLM
analyses. Two sets of primary analyses were conducted. The first analyzed the daily
objective and subjective sleep variables as predictors of next day’s pain score. The
second set of analyses evaluated daily pain on the next night’s objective and subjective
sleep variables. For each daily predictor variable, two different variables were entered
into the model to account for both within- and between-person variation (Hoffman &
Stawski, 2009; Table 5).
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Table 5
HLM Random Coefficient Model
Equations

Example

Level 1 Model

Level 1 Model

Yij = β0j + β1j(XWP) + rij
Level 2 Models

PS = β0j + β1j(TIBWP) + rij
Level 2 Models

β0j = γ00 + γ01(XBP) + u0j

β0j = γ00 + γ01(TIBBP) + u0j

β1j = γ10 + u1j

β1j = γ10 + u1j

Mixed Model

Mixed Model

Yij = γ00 + γ01(XBP) + γ10(XWP) + u0j + u1j(XWP) +
rij

PS = γ00 + γ01(TIBBP) + γ10(TIBWP) + u0j +
u1j(TIBWP) + rij

Note. Equations are from Raudenbush and Bryk (2002); WP = within-person; BP = between-person; PS =
Daily pain score; TIB = Time in Bed

Sleep Variables Predicting Next Day’s Pain
Each objective (actigraphy) and subjective (activity log) sleep predictor variable
was entered into the model individually. This included a within-person variable (Level 1)
that indicated the deviation from that individual’s mean on a particular day, and a
between-person variable (Level 2) that represented that individual’s average for the
predictor across all days.
As shown in Table 6, objective and subjective sleep did not impact next day’s
pain in general (between-person), except for wake after sleep onset (WASO). In other
words, there was not a significant difference between individuals for the relationship of
average objective and subjective sleep variables (Level 2) on daily pain (Level 1),
except for average WASO. Individuals who had more WASO on average experienced
increased daily pain. Similarly, each participant’s daily objective and subjective sleep
did not impact their experience of pain the following day (within-person), except for selfreported refresh score (RS). Participants who reported less than their average refresh
score upon awakening experienced more pain the next day.
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Table 6
Relationship of Objective and Subjective Sleep Predictor Variables on Next Day Pain
Ratings
Daily Pain Outcome
Objective Predictor Variables

Between-Person
(Level 2)

Within-Person
(Level 1)

-0.0008 (0.0026)

0.0002 (0.0005)

Sleep Onset Latency (SOL)

0.0057 (0.0092)

0.0008 (0.0014)

Wake After Sleep Onset (WASO)

0.0140 (0.0061)*

0.0001 (0.0015)

Time in Bed (TIB)

Total Sleep Time (TST)

-0.0046 (0.0030)

0.0002 (0.0005)

Sleep Efficiency (SE)

-0.0288 (0.0186)

-0.0008 (0.0048)

Self-report Time in Bed (SRTIB)

-0.0006 (0.0026)

-0.0000 (0.0004)

Self-report Sleep Onset Latency (SRSOL)

-0.0066 (0.0083)

0.0015 (0.0012)

0.0065 (0.0057)

0.0007 (0.0010)

Self-report Total Sleep Time (SRTST)

-0.0020 (0.0038)

-0.0002 (0.0004)

Self-report Sleep Efficiency (SRSE)

-0.0134 (0.0254)

-0.0024 (0.0034)

Subjective Predictor Variables

Self-report Wake After Sleep Onset (SRWASO)

-0.1326 (0.0364)**
-0.0884 (0.0996)
Refresh Score (RS)
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.
** p = .001, *p < .05.

Daily Pain Predicting Next Night’s Sleep
Each objective (actigraphy) and subjective (activity log) sleep variable was
entered into the model individually as the outcome variable. Daily pain was then added
as the predictor variable, including a within-person variable (Level 1) that indicated the
deviation from that individual’s mean pain score on a particular day, and a betweenperson variable (Level 2) that represented that individual’s average pain score across all
days.
As shown in Tables 7 and 8, average daily pain did not impact the next night’s
objective and subjective sleep in general (between-person), except for wake after sleep
onset (WASO). Individuals who reported greater daily pain on average experienced
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increased nightly WASO. Similarly, each participant’s daily pain did not impact their
objective and subjective sleep the following night (within-person), except for selfreported sleep onset latency (SRSOL). Participants who reported more than their
average pain one day experienced a greater latency to sleep the following night.
Table 7
Relationship of Daily Pain Score Predictor on Objective Sleep Outcome Variables

Daily Pain
Score BP

Time in Bed
(TIB)

Sleep Onset
Latency
(SOL)

Wake After
Sleep Onset
(WASO)

Total Sleep
Time (TST)

Sleep
Efficiency
(SE)

-1.56 (3.83)

0.32 (0.87)

2.99 (1.29)*

-6.03 (3.81)

-0.79 (0.45)

Daily Pain
-0.24 (2.25)
0.38 (0.75)
0.62 (0.81)
0.03 (2.09)
-0.01 (0.21)
Score WP
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. BP = Betweenperson (Level 2); WP = Within-person (Level 1)
*p < .05.

Table 8
Relationship of Daily Pain Score Predictor on Subjective Sleep Outcome Variables

Daily Pain
Score BP

Self-Report
Time in
Bed
(SRTIB)

Self-Report
Sleep
Onset
Latency
(SRSOL)

Self-Report
Wake After
Sleep
Onset
(SRWASO)

Self-Report
Total Sleep
Time
(SRTST)

Self-Report
Sleep
Efficiency
(SRSE)

Refresh
Score
(RS)

-1.28 (3.99)

-0.68 (1.35)

3.06 (2.20)

-1.98 (3.51)

-0.24 (0.49)

-0.09 (0.11)

Daily Pain
1.35 (0.68)*
0.05 (2.70)
-0.01 (1.08)
-0.94 (2.83)
-0.18 (0.25)
-0.03 (0.04)
Score WP
Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses. BP = Betweenperson (Level 2); WP = Within-person (Level 1)
*p < .05.

Level 2 Baseline Measures Predicting Daily Pain Outcome across Individuals
In addition to evaluating the impact of sleep variables on next day’s pain, Level 2
baseline measures of depression, negative affect, sleep quality, age, and pain
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catastrophizing, were each built into the intercepts- and slopes-as-outcomes model
individually to determine their effect on daily pain across individuals (Table 9).
Table 9
HLM Intercepts- and Slopes-as-Outcomes Model with a Level 2 Predictor Only
Equations

Example

Level 1 Model

Level 1 Model

Yij = β0j + rij
Level 2 Model
β0j = γ00 + γ01(Wj) + u0j

PS = β0j + rij
Level 2 Model
β0j = γ00 + γ01(CESD) + u0j

Mixed Model

Mixed Model

Yij = γ00 + γ01(Wj) + u0j + rij

PS = γ00 + γ01(CESD) + u0j + rij

Note. Equations are from Raudenbush and Bryk (2002); PS = Daily pain score; CESD = Depression total
score

As shown in Table 10, baseline depression, negative affect, and sleep quality did
not significantly predict daily pain across individuals. Age was a significant predictor of
daily pain, such that individuals who were older reported less pain, on average, than
those who were younger. Baseline pain catastrophizing was also a significant predictor
of daily pain, such that individuals who reported greater levels of catastrophizing about
their pain reported more pain, on average, than those individuals who reported less
catastrophizing.
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Table 10
Relationship of Baseline Predictors on Daily Pain Outcome across Individuals
Daily Pain Score
Depression (CESD)

0.02 (0.02)

Negative Affect (PANAS)

0.15 (0.28)

Sleep Quality (PSQI)

0.09 (0.04)

Age

-0.05 (0.01)**

Pain Catastrophizing (PCS)

0.74 (0.18)***

Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.
***p < .001, **p = .001

Level 2 Baseline Measures Predicting Objective and Subjective Sleep Outcome
Variables across Individuals
In addition to evaluating the impact of daily pain scores on the next night’s sleep
variables,

Level

2

baseline

measures

of

depression,

negative

affect,

pain

catastrophizing, pain, and age were each built into the intercepts- and slopes-asoutcomes model individually to determine their effect on objective and subjective sleep
variables across individuals.
As shown in Tables 11 and 12, baseline negative affect did not significantly
predict objective or subjective sleep outcome variables across individuals. Depression
was a significant predictor of objective time in bed (TIB) as well as most of the
subjective sleep variables (i.e., self-reported time in bed, self-reported sleep onset
latency, self-reported wake after sleep onset, self-reported sleep efficiency, and refresh
score). Individuals who reported higher levels of baseline depression spent more time in
bed objectively, and reported that they spent more time in bed, took longer to fall
asleep, spent more time awake during the night, and had a lower sleep efficiency than
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those individuals who reported lower levels of depression. In addition, the individuals
who reported higher levels of baseline depression reported feeling less refreshed upon
awakening than those who reported lower levels of depression.
Baseline pain was a significant predictor of refresh score (RS), such that
individuals who reported greater baseline pain also reported feeling less refreshed upon
awakening than individuals who reported lower levels of baseline pain. Age was a
significant predictor of objective sleep onset latency (SOL), such that individuals who
were older took longer to fall asleep than those who were younger. Lastly, baseline pain
catastrophizing was a significant predictor of objective wake after sleep onset (WASO)
and subjective time in bed (SRTIB). Individuals who reported greater levels of
catastrophizing about their pain spent more time awake during the night and reported
spending more time in bed than those individuals who reported lower levels of pain
catastrophizing.
Table 11
Relationship of Baseline Predictors on Objective Sleep Variables across Individuals
Time in Bed
(TIB)

Sleep Onset
Latency
(SOL)

Wake After
Sleep Onset
(WASO)

Total Sleep
Time (TST)

Sleep
Efficiency
(SE)

Depression
(CESD)

1.57 (0.69)*

-0.10 (0.11)

0.41 (0.24)

1.31 (0.67)

0.01 (0.07)

Negative Affect
(PANAS)

7.48 (10.77)

-3.37 (2.08)

-0.48 (3.71)

13.95 (9.41)

1.74 (0.98)

Pain
(BPI)

1.35 (3.42)

0.44 (0.82)

2.29 (1.33)

-2.41 (3.84)

-0.56 (0.48)

Age

0.27 (0.48)

0.30 (0.11)

†

-0.07 (0.20)

0.12 (0.47)

-0.04 (0.06)

Pain
Catastrophizing
(PCS)

8.25 (5.46)

-0.93 (1.67)

6.09 (2.97)*

2.54 (6.03)

-0.90 (0.84)

Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.
†
*p < .05, p < .01.
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Table 12
Relationship of Baseline Predictors on Subjective Sleep Variables across Individuals
Self-Report
Time in
Bed
(SRTIB)

Self-Report
Sleep
Onset
Latency
(SRSOL)

Self-Report
Wake After
Sleep
Onset
(SRWASO)

SelfReport
Total
Sleep
Time
(SRTST)

Self-Report
Sleep
Efficiency
(SRSE)

Refresh
Score
(RS)

Depression
(CESD)

1.69 (0.73)*

0.63 (0.27)*

0.84 (0.42)*

0.39 (0.57)

-0.19 (0.09)*

-0.03 (0.02)*

Negative Affect
(PANAS)

7.10 (11.32)

5.67 (3.74)

3.04 (5.98)

0.57 (8.94)

-0.82 (1.23)

-0.22 (0.24)

Pain
(BPI)

2.26 (3.39)

0.67 (1.07)

3.78 (1.95)

-1.33 (3.32)

-0.74 (0.45)

-0.25 (0.10)*

Age

0.30 (0.48)

0.03 (0.14)

-0.26 (0.30)

0.47 (0.48)

0.03 (0.07)

0.02 (0.02)

11.82 (5.66)*

1.65 (1.92)

3.62 (4.80)

6.81 (6.88)

-0.68 (1.07)

-0.31 (0.26)

Pain
Catastrophizing
(PCS)

Note. Parameter estimates are unstandardized beta coefficients, with SE in parentheses.
*p < .05.

Moderator Analyses
Two sets of moderator analyses were conducted. The first analyzed the potential
moderator variables of age, depression, negative affect, and pain catastrophizing to
determine if each individually predicted the relationship between daily objective and
subjective sleep variables and next day’s pain. The second set of analyses evaluated
the same potential moderator variables to determine if each individually predicted the
relationship between daily pain and the next night’s objective and subjective sleep
variables. Each potential moderator was individually added to the intercepts- and
slopes-as-outcomes model as a continuous variable, and was further described as a
dichotomous variable when a significant interaction term resulted (Preacher, Curran, &
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Bauer, 2006; Table 13). Only those moderator analyses that resulted in a significant
interaction are presented below.
Table 13
HLM Intercepts- and Slopes-as-Outcomes Model
Equations

Example

Level 1 Model

Level 1 Model

Yij = β0j + β1j(XWP) + rij
Level 2 Models

PS = β0j + β1j(TIBWP) + rij
Level 2 Models

β0j = γ00 + γ01(XBP) + γ02(Wj) + u0j

β0j = γ00 + γ01(TIBBP) + γ02(Age) + u0j

β1j = γ10 + γ11(Wj) + u1j

β1j = γ10 + γ11(Age) + u1j

Mixed Model

Mixed Model

Yij = γ00 + γ01(XBP) + γ02(Wj) + γ10(XWP) +
γ11(Wj)(XWP) + u0j + u1j(XWP) + rij

PS = γ00 + γ01(TIBBP) + γ02(Age) + γ10(TIBWP) +
γ11(Age)(TIBWP) + u0j + u1j(TIBWP) + rij

Note. Equations are from Raudenbush and Bryk (2002); WP = within-person; BP = between-person; PS =
Daily pain score; TIB = Time in Bed

Moderators of the Relationship between Sleep and Next Day’s Pain
Age was a significant moderator of the relationship between subjective sleep
onset latency (SOL) and the next day’s pain. Figure 1 indicates that there is a stronger,
positive relationship between subjective SOL and next day’s pain for individuals who are
older (β = 0.004 (0.002), p=0.04), compared with the negative relationship between
subjective SOL and next day’s pain for younger individuals (β = -0.002 (0.002), p=0.52).
In addition to the fact (noted above in Table 10), that older individuals have significantly
lower daily pain than younger people, the interaction indicates that this finding is more
pronounced for individuals with shorter subjective sleep onset latency the previous night
compared with those who report longer sleep onset latency.
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Figure 1. Interaction of daily self-report sleep onset latency (SOL) and age on the next
day’s pain score. Younger and older participants were -1SD and +1SD of the mean
respectively. Daily self-report sleep onset latency was centered around a mean of zero.
Depression was a significant moderator of the relationship between refresh score
and next day’s pain. Figure 2 indicates that there is a stronger, negative relationship
between self-reported refreshing quality of sleep and next day’s pain for individuals who
reported higher levels of baseline depression (β = -0.23 (0.05), p=0.0) than for those
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who reported lower levels of baseline depression (β = -0.04 (0.05), p=0.50). In addition
to the fact (noted above in Table 10), that individuals who reported higher levels of
depression have greater daily pain than those who reported lower levels of depression,
the interaction indicates that this finding is more pronounced for individuals who report
less refreshing quality of sleep from the previous night compared with those who report
more refreshing quality of sleep.
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Figure 2. Interaction of daily refresh score and baseline depression on the next day’s
pain score. Low and high depression were -1SD and +1SD of the mean respectively.
Daily refresh score was centered around a mean of zero.
Negative affect was also a significant moderator of the relationship between
refresh score and next day’s pain. Similar to the findings with depression, Figure 3
indicates that there is a stronger, negative relationship between self-reported refreshing
quality of sleep and next day’s pain for individuals who reported higher levels of
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baseline negative affect (β = -0.22 (0.05), p=0.0) than for those who reported lower
levels of baseline negative affect (β = -0.04 (0.05), p=0.41). In addition to the fact (noted
above in Table 10), that individuals who reported higher levels of negative affect have
greater daily pain than those who reported lower levels of negative affect, the interaction
indicates that this finding is more pronounced for individuals who report less refreshing
quality of sleep from the previous night compared with those who report more refreshing
quality of sleep.
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Figure 3. Interaction of daily refresh score and baseline negative affect on the next
day’s pain score. Low and high negative affect were -1SD and +1SD of the mean
respectively. Daily refresh score was centered around a mean of zero.
Negative affect was a significant moderator of the relationship between objective
total sleep time (TST) and next day’s pain. Figure 4 indicates that there is a small,
negative relationship between objective TST and next day’s pain for individuals who
reported higher levels of baseline negative affect (β = -0.0007 (0.0007), p=0.30),
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compared with a small, positive relationship between objective TST and next day’s pain
for those who reported lower levels of baseline negative affect (β = 0.001 (0.0008),
p=0.13). In addition to the fact (noted above in Table 10), that individuals who reported
higher levels of negative affect have greater daily pain than those who reported lower
levels of negative affect, the interaction indicates that this finding is more pronounced
for individuals who report less total sleep time the previous night compared with those
who report more total sleep time.
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Figure 4. Interaction of objective daily total sleep time (TST) and baseline negative
affect on the next day’s pain score. Low and high negative affect were -1SD and +1SD
of the mean respectively. Daily total sleep time was centered around a mean of zero.
Pain catastrophizing was found to be a significant moderator of the relationship
between objective sleep efficiency (SE) and next day’s pain. Figure 5 indicates that
there is a small, negative relationship between objective SE and next day’s pain for
individuals who reported higher levels of baseline pain catastrophizing (β = -0.0099
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(0.007), p=0.16), and an almost equal positive relationship between objective SE and
next day’s pain for those who reported lower levels of baseline pain catastrophizing (β =
0.0097 (0.008), p=0.24). In addition to the fact (noted above in Table 10), that
individuals who reported higher levels of pain catastrophizing have greater daily pain,
the interaction indicates that this finding is more pronounced for individuals with less
objective sleep efficiency the previous night compared with those who have greater
objective sleep efficiency.
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Figure 5. Interaction of objective daily sleep efficiency (SE) and baseline pain
catastrophizing on the next day’s pain score. Low and high pain catastrophizing were 1SD and +1SD of the mean respectively. Daily sleep efficiency was centered around a
mean of zero.
Moderators of the Relationship between Daily Pain and the Next Night’s Sleep
Age was a significant moderator of the relationship between daily pain and the
next night’s subjective sleep onset latency (SOL). Figure 6 indicates that there is a
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stronger, positive relationship between daily pain and the next night’s subjective SOL for
individuals who are older (β = 2.49 (1.10), p=0.03) compared with those who are
younger (β = 0.09 (1.16), p=0.94). In addition to the fact (noted above in Table 12), that
older individuals have greater self-reported sleep onset latency than younger people,
the interaction indicates that this finding is more pronounced for individuals who report
higher levels of pain the previous day compared with those who report lower levels of
pain.
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Figure 6. Interaction of daily pain score and age on the next night’s self-report sleep
onset latency (SOL). Younger and older participants were -1SD and +1SD of the mean
respectively. Daily pain score was centered around a mean of zero.
Depression was a significant moderator of the relationship between daily pain
and refresh score upon awakening the next morning. Figure 7 indicates that there is a
stronger, negative relationship between daily pain and the next night’s refreshing quality
of sleep for individuals who reported higher levels of baseline depression (β = -0.13
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(0.06), p=0.03), compared with the positive relationship between daily pain and next
night’s refreshing quality of sleep for individuals who reported lower levels of baseline
depression (β = 0.07 (0.06), p=0.24). In addition to the fact (noted above in Table 12),
that individuals who reported higher levels of depression also reported significantly
lower refreshing quality of sleep than those who reported lower levels of depression, the
interaction indicates that this finding is more pronounced for individuals who report
higher levels of pain the previous day compared with those who report lower levels of
pain.
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Figure 7. Interaction of daily pain score and baseline depression on the next day’s
refresh score. Low and high depression were -1SD and +1SD of the mean respectively.
Daily pain score was centered around a mean of zero.
Lastly, pain catastrophizing was found to be a significant moderator of the
relationship between daily pain and the next night’s objective sleep efficiency (SE).
Figure 8 indicates that there is a negative relationship between daily pain and objective
SE for individuals who reported higher levels of baseline pain catastrophizing (β = -0.45
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(0.28), p=0.11), compared with the positive relationship between daily pain and
objective SE for individuals who reported lower levels of baseline catastrophizing (β =
0.42 (0.29), p=0.15). In addition to the fact (noted above in Table 11), that individuals
who reported higher levels of pain catastrophizing have lower objective sleep efficiency
than those who reported decreased levels of pain catastrophizing, the interaction
indicates that this finding is more pronounced for individuals who report higher levels of
pain the previous day compared with those who report lower levels of pain.
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Figure 8. Interaction of daily pain score and baseline pain catastrophizing on the next
night’s objective sleep efficiency (SE). Low and high pain catastrophizing were -1SD
and +1SD of the mean respectively. Daily pain score was centered around a mean of
zero.
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CHAPTER 5
DISCUSSION
This dissertation sought to examine the daily relationship between sleep and pain
in a large population of chronic pain patients with fibromyalgia (FM), as well as the
factors that may explain individual differences in this relationship. This study utilized
actigraphy, an objective measurement of sleep, in addition to self-report daily sleep
diaries. Few studies that have examined the daily sleep and pain relationship have
included an objective measurement of sleep (O’Brien et al., 2011; Tang et al., 2012). In
addition, these previous studies have failed to show a clear relationship between pain
and objectively measured sleep, which may, in part, be due to evaluating populations
that are very heterogeneous with respect to type of pain condition. In this study,
participants with FM wore an actiwatch for two weeks while also completing daily diaries
about their sleep and pain. The constructs of depression, negative affect, pain, sleep
disturbance, and pain catastrophizing were assessed at baseline and tested as
moderators of the daily sleep-pain relationship.
As mentioned previously, poor sleep quality is highly prevalent among individuals
with FM, and is often characterized as light and unrefreshing (Moldofsky, 2008). An
extensive literature of polysomnographic sleep studies has identified common sleep
disturbances in this population including delayed sleep onset (Branco, Atalaia, & Paiva,
1994; Horne & Shackell, 1991), increased arousals (Jennum, Drewes, Andreasen, &
Nielsen, 1993), and lower total sleep time (Harding & Lee-Chiong, 2006) compared with
healthy controls. Self-report is the most common methodology of studying sleep in FM
through the use of sleep diaries and questionnaires such as the PSQI (Buysse et al.,
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1989). Similar to the study by O’Brien and colleagues (2011), the FM population in this
dissertation reported longer sleep onset latency and shorter wake after sleep onset than
was objectively measured with actigraphy. Total sleep time and sleep efficiency in the
current study were similar to prior FM samples as well as healthy controls, suggesting
that the nonrestorative aspect of sleep in the FM population may be due to perceived
quality of sleep rather than amount of actual sleep obtained (Okifuji & Hare, 2011). The
current FM sample also responded similarly to previous FM populations on the PSQI
(Bigatti et al., 2008; Hamilton et al., 2012; O’Brien et al., 2010), providing further support
for the representativeness of the current sample.
The Daily Sleep and Pain Relationship
The first aim of this study was to determine the direction of the sleep and pain
relationship among a sample of participants with FM. Recent reviews of the literature
have established the connection between sleep and pain, although the direction of this
relationship remains unclear (Finan et al., 2013; Moldofsky, 2001). In addition, FM is
characterized by chronic widespread pain, and over 90% of individuals with this
condition report poor sleep quality (Moldofsky, 2008; Wolfe et al., 1990). Therefore, this
study sought to evaluate the direction of the daily sleep and pain relationship within this
population.
In order to examine the intraindividual variability in daily sleep and pain among
participants, hierarchical linear modeling (HLM) was utilized to analyze the daily
objective and subjective sleep variables as predictors of next day’s pain, as well as daily
pain on the next night’s objective and subjective sleep variables. This methodology
accounted for between-person variation (each participant’s deviation from the grand
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mean) and within-person variation (a participant’s daily deviation from their own 14-day
mean), a process that reduced bias and more accurately reflected the relationship
between daily measures and individual differences (Hoffman & Stawski, 2009). I will
begin by discussing the average, between-person analyses of sleep and pain, as well
as how the baseline predictors of depression, negative affect, sleep quality, pain, age,
and pain catastrophizing predicted the daily sleep and pain outcome variables. I will
then transition to the within-person analyses and discuss how these speak to the
direction of the sleep and pain relationship.
Between-Person Sleep and Pain
For each participant and sleep predictor, a between-person variable representing
that individual’s average for the predictor across all days (person mean) was analyzed
to determine if there was an impact on daily pain. Individuals who had more objectivelymeasured wake after sleep onset (WASO), averaged across days, experienced
increased daily pain. Average pain across all 14 days was also analyzed to determine if
there was an impact on the nightly objective and subjective sleep variables. Individuals
who reported greater daily pain, averaged across days, experienced increased nightly
objective WASO. These results provide further support for the relationship between
sleep and pain and are also consistent with the literature that the most common sleep
complaint of individuals with chronic pain is multiple awakenings (Taylor et al., 2007),
and disruption of continuous sleep is more predictive of next day pain (Smith et al.,
2007). However, average, between-person analyses do not speak to the direction of the
sleep and pain relationship. Therefore, within-person, daily analyses are needed, which

58
will be addressed after discussing the between-person analyses of baseline predictors
on sleep and pain.
Between-Person Baseline Predictors on Sleep and Pain
In addition to the established literature linking sleep and pain, several other
variables have been shown to significantly relate to pain, sleep, or both (Edwards et al.,
2006, Goodin et al., 2011, Lunde et al., 2010, Miró et al., 2011). Therefore, the baseline
predictors of depression, negative affect, sleep quality, pain, age, and pain
catastrophizing were each analyzed to determine if they significantly predicted the daily
sleep and pain outcome variables. Age was found to be a significant predictor of daily
pain, such that older individuals reported less pain, on average, than those who were
younger. This is consistent with a recent correlational study that evaluated the
association between aging and pain complaints among emergency room patients
(Marco, Nagel, Klink, & Baehren, 2012). One explanation for this finding is that older
individuals may perceive pain as part of the aging process and therefore underreport
their pain (Klinger & Spaulding, 1998). Age was also a significant predictor of objective
(actigraphy) sleep onset latency (SOL), such that individuals who were older took longer
to fall asleep than those who were younger. This finding is consistent with a much larger
body of literature on the relationship of sleep and aging. Research with both objective
and self-report measures has found that older individuals take longer to fall asleep,
spend more time awake during the night, and have decreased sleep efficiency (Lunde
et al., 2010). In addition, the sleep of older individuals has been characterized as lighter
and less refreshing than those who are younger, a description that has also been used
to describe the sleep of individuals with FM (Crowley, 2011; Moldofsky, 2008).
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Baseline pain catastrophizing was found to be a significant predictor of daily pain,
such that individuals who reported greater levels of catastrophizing about their pain
reported more daily pain, on average, than those who reported less catastrophizing.
This finding is also consistent with the significant positive correlation between baseline
pain catastrophizing and baseline pain, suggesting that those individuals who report
more catastrophizing about their pain are more likely to report greater levels of pain
both retrospectively and prospectively. Indeed, these findings support the substantial
literature linking pain catastrophizing with a heightened pain experience. Diverse patient
groups have displayed this relationship between pain catastrophizing and pain,
including mixed chronic pain, rheumatoid arthritis, low back pain, and fibromyalgia
(Edwards et al., 2006; Flor, Behle, & Birbaumer, 1993; Severeijns et al., 2001; Sullivan
et al., 2001). Research has also shown that catastrophizing accounts for up to 31% of
the variance in pain ratings (Sullivan et al., 2001). Of even greater importance is the
theory behind how catastrophizing is thought to augment the pain experience. Similar to
the concept of an irrationally negative outlook on the future that is associated with the
catastrophizing found in anxiety and depression, pain catastrophizing is the tendency to
exaggerate the level of pain threat coupled with pain-related worry and fear (Chaves &
Brown, 1987; Spanos, Radtke-Bodorik, Ferguson, & Jones, 1979). Pain catastrophizing,
then, appears to augment the experience and reporting of daily pain in this FM sample.
Greater levels of baseline pain catastrophizing were also found to predict
increased objective wake after sleep onset (WASO) and increased subjective time in
bed (SRTIB). These findings suggest that individuals who catastrophize about their
pain, in addition to reporting more daily pain, also objectively experience and
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subjectively report poorer sleep. Although there is significantly less evidence in the
literature of a link between pain catastrophizing and sleep, the studies that have
evaluated this relationship have found an association between higher pain
catastrophizing and poorer sleep with both experimental pain testing and chronic pain
populations (Goodin et al., 2011; Lee et al., 2013).
Patients who reported greater baseline pain also reported feeling less refreshed
upon awakening than individuals who reported lower levels of baseline pain. It is
surprising that baseline pain significantly predicted less refreshing sleep while daily pain
did not. One explanation for this may be the way that pain was assessed at baseline.
Participants were asked to report their worst, least, and average pain over the past
week, as well as their current level of pain at the time of assessment. The interpretation
of this retrospective measure may have actually assessed how participants had been
“feeling” in the past week, including their fatigue, sleepiness, etc, in addition to their
pain. Daily pain assessments, on the other hand, were not retrospective and may have
captured a different aspect of the participants’ pain.
Baseline depression was a predictor of objective time in bed (TIB) as well as
most of the subjective sleep variables. Individuals who reported higher levels of
baseline depression spent more time in bed—and this was confirmed with actigraphy—
and also reported that they took longer to fall asleep, spent more time awake during the
night, had a lower sleep efficiency, and reported feeling less refreshed upon awakening
than those who reported lower levels of depression. These findings are consistent with
the literature on sleep and depression in FM (Miró et al., 2011; Munguia-Izquierdo &
Legaz-Arrese, 2012). A recent study by Roehrs et al. (2013) found that individuals with
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FM reported greater subjective sleepiness and fatigue than individuals with rheumatoid
arthritis or healthy controls, but had the least objective daytime sleepiness as assessed
by the Multiple Sleep Latency Test. It was concluded that this increased latency to sleep
in FM is due to a state of hyperarousal, and this may be particularly true for individuals
with more depression. In addition, one of the diagnostic criteria for Major Depressive
Disorder is sleep disturbance (American Psychiatric Association, 2013). Similar to our
findings, the classic insomnia-type sleep problems in depression are characterized by
reports of difficulty falling asleep, waking intermittently throughout the night, and feeling
unrefreshed upon awakening (Armitage, 2006). The fact that self-reported depression in
our study is more predictive of self-reported poor sleep than of objectively-measured
sleep quality suggests that individuals who are more likely to report high levels of
depression are also more likely to report poor sleep regardless of the sleep they
objectively obtain. This is similar to a study by Edinger et al. (2000) that found that
psychological factors, including depression and anxiety, were related to subjectivelyreported insomnia, but were not related to objectively-recorded sleep.
One aspect of depression is the experience of negative emotion, or negative
affectivity. Surprisingly, baseline negative affect was not predictive of any subjective or
objective sleep variables, suggesting that this construct is at least somewhat distinct
from depression. Whereas high baseline depression was predictive of poorer nightly
sleep, the lack of relationship between negative affect and sleep provides further
support that the construct of depression contains unique aspects beyond negative
affect. Perhaps it is the low positive affect / low energy component of depression that is
more related to sleep difficulties than the negative affect component of depression.
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The finding that baseline depression and negative affect did not significantly
predict daily pain across individuals was surprising given previous literature that
individuals with FM have higher levels of depression than those without a FM diagnosis
and that pain intensity is positively associated with depression (Miró et al., 2011).
Similarly, baseline depression and negative affect were not correlated with baseline
pain, which again is surprising. One possible explanation is that both pain and
depression were elevated in this population and the relationship between these factors
was eliminated due to the narrowed range of scores.
Within-Person Sleep and Pain
As mentioned previously, average, between-person analyses do not speak to the
direction of the sleep and pain relationship, necessitating within-person, daily analyses.
Therefore, the nightly objective and subjective sleep variables were analyzed as
predictors of next day’s pain. Despite the examination of several sleep variables over
the 14-day assessment period, there were relatively few findings. Results showed that
individuals who reported feeling relatively unrefreshed upon awakening experienced
more self-reported pain the rest of the day. This finding is consistent with the
established literature that has found poor self-reported sleep quality to be a predictor of
increased pain (Ağargün et al., 1999; Bigatti et al., 2008; Tang et al., 2012; Theadom et
al., 2007).
Daily pain was also analyzed as a predictor of the next night’s objective and
subjective sleep variables. Only one sleep variable was predicted by daily pain.
Individuals who reported more than their average pain one day experienced a greater
self-reported latency to sleep (SOL) the following night. This suggests that pain does
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not interfere with sleep once it has been initiated, but that it does prevent the onset of
sleep. Increased latency may also represent the hyperarousal state that has been
shown in FM and mentioned previously (Roehrs et al., 2013).
These within-person findings suggest that while there does appear to be a
bidirectional relationship between sleep and pain, this only applies to a few sleep
variables. The strongest relationship was found between daily self-reported refreshing
quality of sleep and next day pain; a finding that is consistent with the literature (Finan
et al., 2013). In the other direction, daily pain was predictive of self-reported sleep onset
latency (SOL) the next night. One thing that is consistent when looking at the day-to-day
relationship between sleep and pain is that this relationship is stronger with subjective
sleep variables than with sleep variables measured with actigraphy. One possible
explanation for this finding is that perception of sleep one night has more influence on
self-reported next-day pain than objectively-measured sleep, and that perception of
daily pain impacts reports of the next night’s sleep more than sleep measured with
actigraphy. Other possible explanations, which will be addressed in the limitations
section, are shared methods variance of self-report predicting self-report for the sleep
and pain variables, as well as a lack of validity in the sleep variables assessed with
actigraphy.
Moderators of the Sleep and Pain Relationship
The second major aim of this dissertation was to determine what individual
difference factors moderate the daily sleep / pain relationship. The baseline measures
of depression, negative affect, age, and pain catastrophizing were analyzed to
determine if each individually predicted the relationship between daily objective and
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subjective sleep variables and next day’s pain as well as the relationship between one
day’s pain and the next night’s objective and subjective sleep variables.
Age was found to significantly moderate the relationship between one night’s
subjective sleep onset latency (SOL) and the next day’s pain, such that older individuals
had a stronger, positive relationship between these variables compared with younger
individuals, who had no relationship between subjective SOL and next day’s pain. As
noted above, older individuals experienced significantly lower daily pain than younger
individuals, but this difference was more pronounced for those individuals who reported
shorter subjective SOL the previous night compared with those who reported longer
SOL. Interestingly, age was also a significant moderator of the relationship between
daily pain and the next night’s subjective SOL, such that there was a stronger, positive
relationship between one day’s pain and the next night’s subjective SOL for individuals
who were older compared with no relationship for those who were younger. Older
individuals had greater self-reported SOL than younger people, and this finding was
more pronounced for individuals who reported higher levels of pain the previous day
compared with those who reported lower levels of pain.
Thus, in older individuals, daily subjective SOL and daily pain are positively
correlated in both directions, and possibly influence each other. In contrast, younger
individuals do not appear to have any relationship between subjective SOL and pain,
but they have higher levels of pain and shorter subjective SOL than individuals who are
older. Perhaps younger individuals have unique characteristics that explain these
findings, such as obtaining less sleep due to work or family obligations. Although not
statistically significant, younger individuals tended to have less time in bed, less total
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sleep time, and more wake after sleep onset than older individuals, suggesting that the
younger participants may have been sleepier, and therefore, experienced more pain.
Another explanation is that as individuals age, there may be adaptation to both affect
and FM, resulting in the condition being less driven by affective dysregulation. Older
people may become more regulated with age, or the FM pain processes may become
less dependent on state factors such as mood and sleep.
Baseline depression was also examined as a potential moderator. Depression
significantly moderated the relationship between refreshing sleep and next day’s pain,
such that more refreshing sleep predicted less pain subsequently, among those
participants who were more depressed at baseline, compared with no relationship for
those who were less depressed. This finding suggests that the perception of sleep
quality has more impact on next day’s pain for those individuals who reported high
levels of baseline depression than those who reported lower levels of depression.
Depression also significantly moderated the relationship between daily pain and refresh
score upon awakening the next morning, such that there was a stronger, negative
relationship between daily pain and the next night’s refreshing quality of sleep for
individuals who reported higher levels of baseline depression compared with the nonsignificant relationship between daily pain and next night’s refreshing quality of sleep for
individuals who reported lower levels of baseline depression. This finding suggests that
there is less impact of baseline depression on refreshing quality of sleep when an
individual experiences less pain the previous day.
Thus, in combination, these two moderator findings indicate that individuals who
report higher levels of baseline depression have a negative relationship between pain
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and refreshing quality of sleep in both directions, with these variables likely reciprocally
influencing one another. That is, among the relatively depressed patients, refreshing
sleep one night leads to less pain the next day, which leads to more refreshing sleep
the following night. In contrast, those who reported lower levels of baseline depression
did not exhibit the expected negative relationship between pain and refreshing quality of
sleep. These findings suggest that the link between pain and sleep exists among those
with depression because higher levels of depression are associated with increased
reports of pain (Miró et al., 2011) as well as feeling unrefreshed upon awakening
(Armitage, 2006). In addition, the relationship between sleep and pain is strengthened
by the presence of depression. The negative sleep and pain relationship for individuals
high in depression may be due to the presence of “subtypes” of FM. One subtype may
be affectively dysregulated, in which a number of systems become disturbed including
sleep, pain, and affect, allowing them to covary more tightly. A contrasting subtype of
FM may have less affect dysregulation and system disruption, so the sleep, pain, and
affect variables do not covary. This is consistent with the subtype model of FM offered
by Turk, Okifuji, Sinclair, and Starz (1996), who proposed that there are “dysregulated,”
“interpersonally distressed,” and “adaptive coper” types of FM patients.
Very similar results were also found with baseline negative affect, such that
there was a stronger, negative relationship between self-reported refreshing quality of
sleep and next day’s pain for individuals who reported higher levels of baseline negative
affect, compared with no relationship for those reporting lower levels of baseline
negative affect. This finding suggests that the construct of negative affect moderates the
relationship of one night’s refreshing quality of sleep on next day’s pain in the same way
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that was found with depression. This may be due to the negative expression of emotion
contained in both depression and negative affect, or may speak to the relationship
between one night’s refreshing quality of sleep on next day’s pain. Individuals who
report low refreshing quality of sleep may also express negative affectivity in general,
suggesting why both high negative affect and high depression would respond similarly.
Negative affect significantly moderated the relationship between objective total
sleep time (TST) and next day’s pain, such that there was a small, negative relationship
between objective TST and next day’s pain for individuals who reported higher levels of
baseline negative affect, compared with a small, positive relationship between objective
TST and next day’s pain for those who reported lower levels of baseline negative affect.
Interestingly, as total sleep time increased, the effect of negative affect on daily selfreported pain attenuated, suggesting that negative affect has a greater impact on daily
pain when an individual has less sleep the previous night.
Pain catastrophizing significantly moderated the relationship between objective
sleep efficiency (SE) and next day’s pain, such that there was a small, negative
relationship between objective SE and next day’s pain for individuals who reported
higher levels of baseline pain catastrophizing and a small, positive relationship between
objective SE and next day’s pain for those who reported lower levels of baseline pain
catastrophizing. This finding suggests that as sleep efficiency increases, baseline pain
catastrophizing has less of an impact on next day’s pain. Pain catastrophizing was also
found to significantly moderate the relationship between daily pain and the next night’s
objective SE, such that there was a negative relationship between daily pain and
objective SE for individuals who reported higher levels of baseline pain catastrophizing
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compared with the almost equally positive relationship between daily pain and objective
SE for individuals who reported lower levels of baseline catastrophizing. This finding
suggests that the interpretation of the experience of pain has a significant impact on the
way that one day’s pain is related to the next night’s sleep efficiency.
Thus, individuals who report higher levels of baseline pain catastrophizing have a
negative relationship between pain and objective sleep efficiency in both directions, with
these variables potentially influencing one another. In contrast, those who reported
lower levels of baseline pain catastrophizing did not exhibit the expected negative
relationship between pain and refreshing quality of sleep. More importantly, the findings
seem to be consistent with the other predictors of baseline depression and age;
individuals who report higher baseline catastrophizing and depression, as well as those
who are older, show the expected “poor sleep and higher pain” relationship. The similar
relationships among these moderator variables suggest a consistent effect. This is not
surprising for baseline pain catastrophizing and baseline depression since these
variables were positively correlated with each other and there are consistent findings in
the literature that individuals who catastrophize about their pain and report symptoms of
depression have poor sleep and increased pain compared with those who are lower in
catastrophizing and depression (Goodin et al., 2011, Miró et al., 2011, Sullivan et al.,
2001). On the other hand, it is surprising that older individuals demonstrated the
expected “poor sleep and higher pain” relationship, especially since they reported lower
levels of depression and pain catastrophizing. One possible explanation for this finding
may be that older individuals had more variability in their daily pain and sleep onset
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latency (SOL) than younger individuals, allowing for a relationship between sleep and
pain.
Limitations of the Study
Although this study has many strengths, such as the use of a relatively large and
homogeneous chronic pain population of individuals with FM, and the utilization of both
objective and subjective measures of sleep, there are several limitations that I will now
address. One limitation is that all of the participants were individuals who sought
participation in a treatment study for stress. Thus, this self-selected sample may have
unique characteristics, such as having high rates of affect disorders, trauma histories,
etc. that are not representative of the larger FM population. Results should therefore be
interpreted with caution. Additionally, the study sample consisted of only individuals with
a diagnosis of FM; therefore, the findings may not be generalizable to other chronic pain
populations, particularly conditions with younger individuals, with more men, and that
have pain with less affective dysregulation.
Another limitation is the use of paper diaries for collecting daily subjective sleep
and pain variables. Although the participants were taught how to complete the diaries
and when to answer the various questions about their sleep and pain, there was no
independent validation of when the diary was completed. Similarly, the use of a oncedaily pain rating collected on paper is a limitation of the study. Assessing pain at
multiple points throughout the day and utilizing electronic diaries for sleep and pain
variables would ensure timely completion of these temporal variables and allow for
analyses of daily pain fluctuation. All of the diary data were also based on self-report
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measures of sleep and pain. Therefore, the relationships found among the variables
may be accounted for, at least in part, by shared method variance.
The study is also correlational in nature, rather than experimental. Therefore, no
definitive causal interpretations can be made about the sleep and pain relationship.
Although the data suggest a potential bidirectional relationship, there were no good
estimates for determining which direction of the effect is stronger. Another limitation of
the study is that the lag was only one day, assessing one night’s sleep on next day’s
pain and one day’s pain on the next night’s sleep. It is possible that effects took longer
to manifest and longer lag periods should have been tested in the analyses.
Additionally, increasing the study period beyond 14 days may have also resulted in
more reliable estimates.
The utilization of actigraphy, although a strength for collecting objective sleep
data, may also be a limitation of this study. Actiwatches are an excellent method for
assessing participant movement, but there is some question about the validity of sleep
variables collected with actigraphy. Although assessment studies have shown a high
level of agreement for sleep scored from polysomnography and actigraph algorithms (r
= 0.85), this is only for normal individuals (Acebo, 2006). Accuracy of sleep and wake
measured with actigraphy tends to decrease when sleep is disturbed, as is often the
case in chronic pain populations (Kushida et al., 2001). There is also little evidence for
the validity of several sleep variables collected with actigraphy, including sleep onset
latency and wake after sleep onset (Acebo, 2006). In addition, actigraphy was scored
with the aid of self-reported diary variables that include limitations stated above. For
example, many participants had periods of “inactivity” as measured with actigraphy that
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did not correspond to the times that were recorded in the diary for sleep. Therefore, it
was unclear if the participants were asleep, sitting very still, or had removed the
actiwatch during these periods. Ambiguous periods of time were eliminated from
analyses, which may have underestimated the total sleep time for some participants.
Another limitation of the study is that it would have been ideal to assess more
measures during the daily recording period. Negative affect, depressive symptoms, and
pain catastrophizing were assessed as trait-type measures, asking participants to
respond based on how they typically feel over longer periods of time. These measures
could also have been assessed from day to day, allowing me to test how they
influenced the sleep / pain relationship. Another measure that would have been ideal to
assess daily is pain interference. The long version of the Brief Pain Inventory (BPI;
Cleeland & Ryan, 1994) consists of a pain interference component in addition the pain
intensity component assessed at baseline in this study. Daily pain interference may be a
more important outcome measure than pain intensity for determining the impact of poor
sleep the previous night.
The final limitation is the analysis of so many objective and subjective sleep
variables in the analyses. Sleep efficiency was predicted to be the sleep variable of
interest for this study, but it was not significantly related to daily pain in unmoderated
relationships. Other sleep variables were then analyzed to determine their relationship
with daily pain, and very few of the analyzed variables resulted in significant findings.
Therefore, there is concern regarding Type 1 error for these sleep variables, and the
results should be interpreted with caution.
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Implications and Future Directions
This study suggests that there is a bidirectional relationship between sleep and
pain, with daily refreshing quality of sleep predicting next day’s pain, and one day’s pain
predicting the next night’s subjective sleep onset latency. Average objective wake after
sleep onset also predicted daily pain, and daily pain predicted average objective wake
after sleep onset. In addition to the daily sleep and pain findings, several factors that
explained individual differences in the sleep and pain relationship including depression,
negative affect, age, and pain catastrophizing were assessed as moderators. Age,
depression, and pain catastrophizing all exhibited bidirectional moderation of the sleep
and pain relationship; age moderated the self-report sleep onset latency and pain
relationship, depression moderated the refreshing quality of sleep and pain relationship,
and pain catastrophizing moderated the objective sleep efficiency and pain relationship.
In addition, individuals who were older as well as those who reported higher levels of
baseline depression and pain catastrophizing demonstrated the expected results of
poorer sleep being associated with increased pain. The similar relationships among
these moderator variables suggest a consistent effect. These findings provide more
support for the temporal relationship of daily sleep and pain and indicate that there are
individual factors that should be considered in evaluating this relationship.
There are many questions that remain unanswered, however. Although there
was a relationship between sleep and pain for a few select sleep variables, it is unclear
as to why other objective and subjective sleep variables were not associated with daily
pain. It is also unclear why depression and negative affect were not related to baseline
pain or daily pain. This finding is not consistent with the literature, and future studies
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should evaluate the relationship of depression and negative affect with pain to
determine if this finding can be replicated. Future studies should also explore increasing
the length of sleep and pain data collection as well as other methodologies for collecting
diary data that increase the reliability of temporal self-report measures.
In conclusion, this dissertation adds to the established literature on the
relationship between sleep and pain, utilizing objective and subjective measures of
sleep within a large chronic pain population of individuals with FM. Future research
should focus on individual differences in the sleep and pain relationship in order to
determine if there are more significant moderation relationships among these variables.
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APPENDIX A: ACTIWATCH LOG

INSTRUCTIONS
Thank you for agreeing to take part in our study and wearing the Actiwatch.
This watch-like device records your daily movement and will help us better
understand sleep-wake cycles, activity levels, and daily pain ratings. The
information you provide in this workbook will help the researchers analyze the
data captured on your Actiwatch.
Fill out the questions in this book each day you are asked to wear the Actiwatch.
Morning questions are about the previous night’s sleep.
At the end of each day, we ask you to record your average pain rating for the day
in this logbook.

Some reminders:
• Wear the watch on your non-dominant wrist.
• There is no need to turn the watch on, it will begin recording by itself. The
watch does not appear to be doing anything, but it is recording your
movement.
• Please note in your logbook anytime during the day you take the watch off
(to shower, etc).
• Bring your watch and logbook with you to your next study visit.

Please contact the study coordinator if you have any questions or concerns about
wearing this device.
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Day 1

Today's Date: __ __ / __ __ / __ __ __ __

Mon / Tue / Wed / Thu / Fri / Sat / Sun

Morning Questions
1. What time did you turn off the light and try to go to sleep last night?
: AM / PM
2. How many minutes did it take you to fall asleep last night?
 minutes
3. How many times did you wake up last night before you woke up to start your day?
 times
4. How many total minutes were you awake last night from these awakenings?
 minutes
5. What time did you wake up this morning to start your day?
: AM / PM
6. Using the scale below, please rate how refreshed you feel after last night’s sleep.
0

1

2

3

4

5

6

7

8

9

10

Not at all
refreshed

Completely
refreshed

Evening Questions
7. Did you take off the watch today (to shower, swim, etc.)? If so, please record:
Time that I took off the watch
Approx length of time watch was off
 minutes
: AM / PM
 minutes
: AM / PM
 minutes
: AM / PM
 minutes
: AM / PM
8. Using the scale below, please rate your average pain today.
0

1

2

3

4

5

6

7

8

No
Pain

9

10
Pain as bad as
you can imagine

- End of questions for today–
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APPENDIX B: BASELINE MEASURES
CES-D
Below is a list of ways you might have felt or behaved. Please indicate how often you have felt
this way during the PAST WEEK by placing a check in the box below your response.
Rarely or
none of the
time
(less than 1
day)
In the past week:
1. I was bothered by things that
usually don't bother me.
2. I did not feel like eating; my
appetite was poor.
3. I felt that I could not shake off the
blues even with help from my
family or friends.
4. I felt that I was just as good as
other people.
5. I had trouble keeping my mind on
what I was doing.
6. I felt depressed.
7. I felt that everything that I did as
an effort.
8. I felt hopeful about the future.
9. I thought that my life had been a
failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people dislike me.
20. I could not get going

Some or a
little of the
time
(1 to 2 days)

Occasionally
or a
moderate
amount of
the time
(3 to 4 days)

Most or all
of the time
(5 to 7 days)
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PCS
Everyone experiences painful situations at some point in their lives. Such experiences may
include headaches, tooth pain, joint or muscle pain. People are often exposed to situations that
may cause pain such as illness, injury, dental procedures or surgery.
Instructions:
We are interested in the types of thoughts and feelings that you have when you are in pain.
Listed below are thirteen statements describing different thoughts and feelings that may be
associated with pain. Using the following scale, please indicate the degree to which you have
these thoughts and feelings when you are experiencing pain.
RATING

0

1

2

3

4

MEANING

Not at all

To a slight
degree

To a
moderate
degree

To a great
degree

All the time

When I’m in pain …
Number

Statement

1

I worry all the time about whether the pain will end.

2

I feel I can’t go on.

3

It’s terrible and I think it’s never going to get any better

4

It’s awful and I feel that it overwhelms me.

5

I feel I can’t stand it anymore

6

I become afraid that the pain will get worse.

7

I keep thinking of other painful events

8

I anxiously want the pain to go away

9

I can’t seem to keep it out of my mind

10

I keep thinking about how much it hurts.

11

I keep thinking about how badly I want the pain to stop

12

There’s nothing I can do to reduce the intensity of the pain

13

I wonder whether something serious may happen.

Rating
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BPI

1. Please rate your pain by circling the one number that best describes your pain at its worst in the
last week.

0

1

2

3

4

5

6

7

8

No pain

9

10

Pain as bad as
you can imagine

2. Please rate your pain by circling the one number that best describes your pain at its least in the
last week.

0

1

2

3

4

5

6

7

8

No pain

9

10

Pain as bad as
you can imagine

3. Please rate your pain by circling the one number that best describes your pain on the average for
the last week.

0

1

2

3

4

5

6

7

8

No pain

9

10

Pain as bad as
you can imagine

4. Please rate your pain by circling the one number that tell how much pain you have right now.

0
No pain

1

2

3

4

5

6

7

8

9

10

Pain as bad as
you can imagine
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PSQI
Instructions: The following questions relate to your usual sleep habits during the past month
only. Your answers should indicate the most accurate reply for the majority of days and nights in
the past month. Please answer all questions.
During the past month,
1. What TIME have you usually gone to bed? ________________________
2. How long (in minutes) has it taken you to fall asleep each night? _______________________
3. What TIME have you usually gotten up in the morning? _______________________
4. How many hours of actual sleep do you get at night? (This may be different than the number of hours
you spend in bed) _______________________
5. During the past month, how often have you had
trouble sleeping because you…

Not during
the past
month
(0)

Less that
once a
week
(1)

Once or
twice a
week
(2)

Three or
more
times a
week
(3)

Very Good
(0)

Fairly
Good
(1)

Fairly
Bad
(2)

Very Bad
(3)

a. Cannot get to sleep within 30 minutes
b. Wake up in the middle of the night or early
morning
c. Have to get up to use the bathroom
d. Cannot breathe comfortably
e. Cough or snore loudly
f. Feel too cold
g. Feel too hot
h. Have bad dreams
i. Have pain
Other reason(s), please describe, including how
j. often you have trouble sleeping because of this
reason(s):
6. During the past month, how often do you take
medicine (prescribed or “over the counter”) to
help you sleep?
7. During the past month, how often have you had
trouble staying awake while driving, eating
meals, or engaging in social activity?
8. During the past month, how much of a problem
has it been for you to keep up enthusiasm to get
things done?

9. During the past month, how would you rate
your sleep quality overall?
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PANAS

This scale consists of a number of words and phrases that describe different feelings and
emotions. Read each item and then circle the number that corresponds to the appropriate
answer. Indicate to what extent you have felt this way during the past few weeks. Use the
following scale to record your answers:

Very
slightly or
not at all
1.

interested

2.

irritable

3.

distressed

4.

alert

5.

excited

6.

ashamed

7.

upset

8.

inspired

9.

strong

10. nervous
11. guilty
12. determined
13. scared
14. attentive
15. hostile
16. jittery
17. enthusiastic
18. active
19. proud
20. afraid

A little

Moderately

Quite a bit

Extremely
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Fibromyalgia (FM) impacts millions of individuals around the world and is
characterized by widespread chronic pain and tenderness as well as nonrestorative
sleep, fatigue, and stiffness (Wolfe et al., 1990; Wolfe et al., 2010). Poor sleep quality is
reported by more than 90% of individuals with FM, suggesting that sleep disturbance
may be a contributing factor to the pain experience (Moldofsky, 2008). Recent reviews
of the literature have established the connection between sleep and pain, although the
direction of this relationship remains unclear (Finan et al., 2013; Moldofsky, 2001). This
dissertation sought to examine the daily relationship between sleep and pain in a large
population of chronic pain patients with fibromyalgia (FM), as well as the factors that
may explain individual differences in this relationship. Ninety adults with FM completed
baseline self-report measures of depression, negative affect, pain, sleep disturbance,
and pain catastrophizing. Participants also wore an actiwatch, an objective
measurement of sleep, for two weeks while completing daily diaries about their sleep
and pain. Hierarchical linear modeling (HLM) was utilized to examine the intraindividual

94
variability in daily sleep and pain among participants, as well as the baseline factors that
explain individual differences in this relationship.
Results of this study suggest that there is a bidirectional relationship between
sleep and pain, with daily refreshing quality of sleep predicting next day’s pain, and one
day’s pain predicting the next night’s self-reported sleep onset latency. Average
objective wake after sleep onset also predicted daily pain, and daily pain predicted
average objective wake after sleep onset. In addition to the daily sleep and pain
findings, several factors that explained individual differences in the sleep and pain
relationship including depression, negative affect, age, and pain catastrophizing were
assessed as moderators. Age, depression, and pain catastrophizing all exhibited
bidirectional moderation of the sleep and pain relationship, and individuals who were
older as well as those who reported higher levels of baseline depression and pain
catastrophizing demonstrated the expected results of poorer sleep being associated
with increased pain. The similar relationships among these moderator variables suggest
a consistent effect. These findings provide more support for the temporal relationship of
daily sleep and pain and indicate that there are individual factors that should be
considered in evaluating this relationship.
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